BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20946627)

  • 1. Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
    Habte HH; de Beer C; Lotz ZE; Roux P; Mall AS
    Virol J; 2010 Oct; 7():269. PubMed ID: 20946627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
    Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
    Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
    McQuaid IK; Dorfman JR; Mall AS
    Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1.
    Peacocke J; Lotz Z; de Beer C; Roux P; Mall AS
    Virol J; 2012 Aug; 9():177. PubMed ID: 22929306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7.
    Rousseau K; Wickstrom C; Whitehouse DB; Carlstedt I; Swallow DM
    Hybrid Hybridomics; 2003 Oct; 22(5):293-9. PubMed ID: 14678646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of MUC7 and MUC5B in human saliva.
    Takehara S; Yanagishita M; Podyma-Inoue KA; Kawaguchi Y
    PLoS One; 2013; 8(7):e69059. PubMed ID: 23874867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
    Wickström C; Christersson C; Davies JR; Carlstedt I
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori.
    Silva DG; Stevens RH; Macedo JM; Hirata R; Pinto AC; Alves LM; Veerman EC; Tinoco EM
    Arch Oral Biol; 2009 Jan; 54(1):86-90. PubMed ID: 18817906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC7 Level As A New Saliva Risk Factor For Dental Caries In Adult Patients.
    Szkaradkiewicz-Karpińska AK; Ronij A; Goślińska-Kuźniarek O; Przybyłek I; Szkaradkiewicz A
    Int J Med Sci; 2019; 16(2):241-246. PubMed ID: 30745804
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucins MUC5B and MUC7 in minor salivary gland secretion of children and adults.
    Sonesson M; Wickström C; Kinnby B; Ericson D; Matsson L
    Arch Oral Biol; 2008 Jun; 53(6):523-7. PubMed ID: 18282555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B.
    Nielsen PA; Bennett EP; Wandall HH; Therkildsen MH; Hannibal J; Clausen H
    Glycobiology; 1997 Apr; 7(3):413-9. PubMed ID: 9147051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reorganisation of the salivary mucin network by dietary components: insights from green tea polyphenols.
    Davies HS; Pudney PD; Georgiades P; Waigh TA; Hodson NW; Ridley CE; Blanch EW; Thornton DJ
    PLoS One; 2014; 9(9):e108372. PubMed ID: 25264771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural localization of salivary mucins MUC5B and MUC7 in human labial glands.
    Piras M; Hand AR; Tore G; Ledda GP; Piludu M
    Eur J Oral Sci; 2010 Feb; 118(1):14-8. PubMed ID: 20156260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Mucin-7 (Muc7) Sialylation and Altered Saliva Rheology in Sjögren's Syndrome Associated Oral Dryness.
    Chaudhury NM; Proctor GB; Karlsson NG; Carpenter GH; Flowers SA
    Mol Cell Proteomics; 2016 Mar; 15(3):1048-59. PubMed ID: 26631508
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chahal G; Quintana-Hayashi MP; Gaytán MO; Benktander J; Padra M; King SJ; Linden SK
    Front Cell Infect Microbiol; 2022; 12():889711. PubMed ID: 35782137
    [No Abstract]   [Full Text] [Related]  

  • 16. MUC5B glycosylation in human saliva reflects blood group and secretor status.
    Thomsson KA; Schulz BL; Packer NH; Karlsson NG
    Glycobiology; 2005 Aug; 15(8):791-804. PubMed ID: 15814823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x.
    Karlsson NG; Thomsson KA
    Glycobiology; 2009 Mar; 19(3):288-300. PubMed ID: 19043084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of MUC7 in submandibular, sublingual, palatine, and labial saliva by anti-peptide antiserum.
    Bolscher JG; Groenink J; van der Kwaak JS; van den Keijbus PA; van 't Hof W; Veerman EC; Nieuw Amerongen AV
    J Dent Res; 1999 Jul; 78(7):1362-9. PubMed ID: 10403464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assay.
    Habte HH; de Beer C; Lotz ZE; Tyler MG; Schoeman L; Kahn D; Mall AS
    Virol J; 2008 May; 5():59. PubMed ID: 18489743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of salivary mucins in children with deciduous and mixed dentition: comparative analysis between high and low caries-risk groups.
    Angwaravong O; Pitiphat W; Bolscher JG; Chaiyarit P
    Clin Oral Investig; 2015 Nov; 19(8):1931-7. PubMed ID: 25689982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.